http://biz.yahoo.com/ic/news/513.htmlThe latest news on the Drug Delivery industry from Yahoo! Financeen-usFri, 18 Dec 2009 13:00:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091218/20091218005222.html?.v=1LYON, France----Flamel Technologies today announced the initiation of a Phase 2a clinical trial of Flamel’s Interferon alpha-2b XL , which is based on Flamel’s Medusa® platform for controlled release of biologics.yahoo_finance/2581360170Fri, 18 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091218/180567.html?.v=1yahoo_finance/1753075994Fri, 18 Dec 2009 11:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091217/28450.html?.v=1Johnson & Johnson has been in an acquisitive mode during the year, the Acclarent buyout being the latest.yahoo_finance/3986210123Thu, 17 Dec 2009 21:30:58 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091217/180481.html?.v=1WORCESTER, Mass. -- Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has recently initiated shipments and generated sales of its confectionary product line, including Glucose RapidSpray , Crave-NX 7-Day Diet Aid Spray , and BaBoom!yahoo_finance/3946177114Thu, 17 Dec 2009 13:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091216/cg27274.html?.v=1Hospira, Inc. , a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its fourth-quarter and full-year 2009 results and projections for 2010 on Thursday, Feb. 4, 2010, at 8 a.m.yahoo_finance/1368065072Wed, 16 Dec 2009 18:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091216/28363.html?.v=1yahoo_finance/342812775Wed, 16 Dec 2009 15:01:10 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091215/20091215006424.html?.v=1ALAMEDA, Calif.----InSite Vision Incorporated , a company developing ophthalmic products for unmet eye care needs, today announced plans to advance new development candidate ISV-303, a topical anti-inflammatory product intended to reduce the pain and swelling associated with ocular surgery.yahoo_finance/3441412629Tue, 15 Dec 2009 22:29:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091215/cg25738.html?.v=1Hospira, Inc. , the world leader in generic injectable pharmaceuticals, and Orchid Chemicals & Pharmaceuticals Ltd. , a leading Indian pharmaceuticals company and among the top-five generic beta-lactam antibiotics manufacturers globally, today announced an agreement for Hospira to acquire Orchid's generic injectable finished-dosage form pharmaceuticals business for approximately $400 million.yahoo_finance/2425724420Tue, 15 Dec 2009 16:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12o07vp85/*http%3A//www.marketwatch.com/news/story/elan-partially-shuts-down-alzheimer/story.aspx?guid=%7BCC5B9833%2DF261%2D43EF%2DAAD1%2D65A5928D080D%7D&siteid=yhoofyahoo_finance/1619365773Tue, 15 Dec 2009 15:14:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12o831h8i/*http%3A//www.marketwatch.com/news/story/elan-partially-shuts-down-alzhiemer/story.aspx?guid=%7BCC5B9833%2DF261%2D43EF%2DAAD1%2D65A5928D080D%7D&siteid=yhoofElan Corp. said early Tuesday said that it was discontinuing testing of a higher dose of its Alzheimer's disease drug candidate after nine deaths were reported in a Phase II clinical study.yahoo_finance/152935562Tue, 15 Dec 2009 15:09:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091215/180332.html?.v=1WORCESTER, Mass. -- On December 14, 2009, Generex Biotechnology Corporation issued a press release announcing the presentation of interim results from a Phase II efficacy study of a novel immunotherapeutic vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc. , at the 32nd Annual San Antonio Breast Cancer Symposium .yahoo_finance/1340738057Tue, 15 Dec 2009 14:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091215/20091215005238.html?.v=1FLEMINGTON, N.J.----NovaDel Pharma Inc. , today announced that it received an Issue Notification from the United States Patent and Trademark Office for a new U.S. Patent, No. 7632517, entitled “Buccal, Polar and Non-polar Spray Containing Zolpidem,” which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaDel’s oral spray technology.yahoo_finance/1807599457Tue, 15 Dec 2009 14:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11kitjnkn/*http%3A//www.marketwatch.com/News/Story/Story.aspx?guid=%7bBBEF71DA-B98F-47F3-8ADA-6133CD396072%7d&siteid=yhoof2yahoo_finance/1248908307Tue, 15 Dec 2009 13:03:40 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091215/20091214006410.html?.v=1DUBLIN----Elan Corporation, plc and Transition Therapeutics, Inc. today notified clinical investigators of modifications to the Phase II study AD201 and open label extension study AD251 for ELND005, a compound being developed for the potential treatment of Alzheimer’s disease.yahoo_finance/3482809013Tue, 15 Dec 2009 07:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091214/us_generex_cancer_vaccine.html?.v=1Biotech drugmaker Generex on Monday reported positive results for a mid-stage study of its experimental cancer vaccine. The company said data after 13 months showed only half of breast cancer patients who received the company's vaccine relapsed, compared with those not taking the vaccine.yahoo_finance/3553274948Mon, 14 Dec 2009 23:01:59 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091214/180278.html?.v=1NEW YORK -- Harwood Feffer LLP today announced that it continues to file actions on behalf of individuals who have experienced a total or partial loss of smell after using Zicam products.yahoo_finance/41212393Mon, 14 Dec 2009 20:17:09 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12j28vsj6/*http%3A//sanfrancisco.bizjournals.com/sanfrancisco/stories/2009/12/14/daily1.html?ana=yfcpcyahoo_finance/787139614Mon, 14 Dec 2009 18:05:27 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091214/20091214005874.html?.v=1HOUSTON----Bio-Path Holdings, Inc. , a publicly traded biotechnology company with drug development operations in Houston, Texas, issued a news release today that disclosed the closing of a private placement fund-raising round.yahoo_finance/3503491417Mon, 14 Dec 2009 16:20:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091214/180167.html?.v=1WORCESTER, Mass. -- Generex Biotechnology Corporation today announced presentation of interim results from a Phase II efficacy study of a novel immunotherapeutic vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc. .yahoo_finance/2740825866Mon, 14 Dec 2009 14:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091214/20091214005335.html?.v=1LIVINGSTON, N.J.----Columbia Laboratories, Inc. today announced the appointment of Frank C. Condella, Jr. as interim chief executive officer. Mr. Condella, who has served on Columbia’s board of directors since March of this year, will begin serving as chief executive officer effective December 15.yahoo_finance/3534073951Mon, 14 Dec 2009 14:00:00 Etc/GMT